FLGT Fulgent Genetics: Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan

The EV/EBITDA valuation trend for Fulgent Genetics, Inc. (FLGT) reflects the dynamics of the company's partnerships with the public sector and clinics. Long-term contracts with medical networks support margin stability, although stricter FDA regulations and falling demand for COVID tests have reduced client inflow. The 0.00 mark indicates the business value relative to operating profit, helping to assess the asset's investment attractiveness.

Fulgent Corp - Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan FLGT (periode 23.11.2025 - 12.11.2026)

Rincian metrik keuangan lan pasar fulgentgenetics.com (FLGT)

- rega saham lan target rega konsensus:

Kutipan saham Fulgent Corp|FLGT - Rata-rata rega prakiraan

- data kapitalisasi saham perusahaan:

Nilai pasar Fulgent|FLGT - Rega Tumbas Perusahaan

- indikator nilai buku ekuitas:

Nilai Buku saben Saham Fulgent Genetics|FLGT - Pambiji Buku Bisnis|Rasio Nilai Pasar marang Nilai Buku fulgentgenetics.com|FLGT - Gunggung Aset Perusahaan

- data liabilitas lan likuiditas perusahaan:

Total Utang marang Modal Fulgent Genetics, Inc.|FLGT - Kewajiban jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Fulgent Genetics|FLGT - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Fulgent|FLGT - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Fulgent Genetics|Rasio cepet fulgentgenetics.com

- rincian asil keuangan lan kelipatan valuasi:

FLGT - Penghasilan resik perusahaan|Bathi sing dikarepake Fulgent Genetics, Inc.|FLGT - Pangali rega marang bathi|Prakiraan rega marang bathi Fulgent Genetics, Inc.|FLGT - Rasio nilai perusahaan marang wutah bathi|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Fulgent|FLGT - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Fulgent Genetics|FLGT - Bathi resik saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan fulgentgenetics.com|FLGT - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Fulgent Genetics, Inc.

Analisis fundamental perusahaan:FLGT (Fulgent Corp)

Given the low cyclicality of genetic diagnostics at Fulgent Genetics, Inc. (FLGT), the EV/EBITDA multiple on the time chart demonstrates the resilience of the business value relative to its operating profit. This indicator aggregates market capitalization and net debt, dividing them by earnings before depreciation and amortization, which allows an investor to assess the actual payback period of the asset while accounting for the debt load.

Karo sapa Fulgent Genetics, Inc. saingan